WASHINGTON — President Trump’s much-ballyhooed drug pricing address Friday contained little of the fiery rhetoric that so often accompanies his campaign speeches and off-script asides. And the policy document that was supposed to detail his vague remarks offered more flash than specifics.
It’s unclear how the bevvy of proposals would work independently or together to actually save money for patients. The blueprint offers few specific details about how any of these ideas would be implemented, and barely commits the government to doing anything, often saying that the Department of Health and Human Services “may” take certain actions.
In remarks following Trump’s speech and in a subsequent question-and-answer period, Health and Human Services Secretary Alex Azar did his best to flesh out what’s to come from the administration, going into detail about some of the policies he’s most eager to implement.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
